Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression
- 15 November 2004
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (22), 8199-8207
- https://doi.org/10.1158/0008-5472.can-03-3639
Abstract
The mechanisms for “gain-of-function” phenotypes produced by mutant p53s such as enhanced proliferation, resistance to transforming growth factor-β–mediated growth suppression, and increased tumorigenesis are not known. One theory is that these phenotypes are caused by novel transcriptional regulatory events acquired by mutant p53s. Another explanation is that these effects are a result of an imbalance of functions caused by the retention of some of the wild-type transcriptional regulatory events in the context of a loss of other counterbalancing activities. An analysis of the ability of DNA-binding domain mutants A138P and R175H, and wild-type p53 to regulate the expression levels of 6.9 × 103 genes revealed that the mutants retained only <5% of the regulatory activities of the wild-type protein. A138P p53 exhibited mostly retained wild-type regulatory activities and few acquired novel events. However, R175H p53 possessed an approximately equal number of wild-type regulatory events and novel activities. This is the first report that, after examination of the regulation of a large unfocused set of genes, provides data indicating that remaining wild-type transcriptional regulatory functions existing in the absence of counterbalancing activities as well as acquired novel events both contribute to the gain-of-function phenotypes produced by mutant p53s. However, mutant p53s are likely to be distinct in terms of the extent to which each mechanism contributes to their gain-of-function phenotypes.Keywords
Other Versions
This publication has 49 references indexed in Scilit:
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsOncogene, 2001
- Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNABiochemical and Biophysical Research Communications, 2000
- Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53Molecular and Cellular Biology, 2000
- Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapyOncogene, 2000
- Twenty years of p53 research: structural and functional aspects of the p53 proteinOncogene, 1999
- p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin GenePublished by Elsevier BV ,1999
- p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene ExpressionPublished by Elsevier BV ,1999
- `Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domainOncogene, 1998
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993